Skip to main navigation
Skip to search
Skip to main content
Sort by
Keyphrases
Adult Spinal Deformity Surgery
80%
Adult Spinal Deformity
32%
Pelvis
27%
Patient-Reported Outcomes Measurement Information System (PROMIS)
26%
Risk Factors
25%
Operative
21%
Proximal Junctional Kyphosis
19%
Nonoperative
17%
Posterior-only
15%
Lumbar Lordosis
15%
Estimated Blood Loss
13%
Revision Surgery
13%
Randomized Controlled Trial
11%
Clinical Outcomes
11%
Minimally Invasive Surgery
11%
Physical Function
11%
Decision Regret
11%
Neurological Deficit
10%
MFI-5
10%
Nonoperative Care
9%
Operative Treatment
9%
Spine Surgery
9%
Cervical Spine Surgery
9%
Motion Preservation
9%
M6-C
9%
Lumbar Scoliosis
9%
Delayed Failure
9%
Cervical Disc Replacement
9%
Cervical Disc Arthroplasty
9%
Corrective
9%
Decisional Regret
9%
Single Institution Study
9%
Tranexamic Acid
9%
Dosing Protocol
9%
Ligament Reconstruction
9%
Randomized pilot Trial
9%
Suture Tape
9%
Prospective Randomized Trial
9%
1-year Outcome
9%
Suspensionplasty
9%
Tendon Interposition
9%
Ligament Reconstruction Tendon Interposition
9%
Thumb Carpometacarpal Joint Arthritis
9%
Body Mass Index
9%
Decision Regret Scale
9%
Sporting Activity
9%
Delayed Ambulation
9%
Activities of Daily Living
9%
Return to Activity
9%
Long Fusion
9%
Medicine and Dentistry
Adult Spine Deformity
100%
Pelvis
32%
Patient-Reported Outcome
25%
Surgeon
21%
Scoliosis
20%
Spine Surgery
19%
Kyphosis
19%
Outcome Assessment
17%
Bleeding
17%
Osteotomy
15%
Lordosis
15%
Arthritis
12%
Body Mass Index
11%
Minimally Invasive Procedure
11%
Randomized Controlled Trial
11%
Knee
11%
Spine Malformation
9%
Arthroplasty
9%
Athletes
9%
Total Disc Replacement
9%
Systematic Review
9%
Valgus Deformity
9%
Cervical Spine
9%
Tranexamic Acid
9%
Ligament Surgery
9%
Thumb
9%
Carpometacarpal Joint
9%
Suture
9%
Posterior Lumbar Interbody Fusion
9%
Hyperextension
9%
Quality Improvement
9%
Greenhouse Gas Emissions
9%
Weakness
9%
Retrospective Cohort Study
9%
Frailty
7%
Cross Sectional Study
6%
Osteoarthritis
5%
Adverse Event
5%
Femoral Nerve
5%
Conservative Treatment
5%
Quality of Life
5%